chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt felt faint after receiving ADACEL, MENACTRA and GARDASIL. She then became opisthotonic, began salivating, eyes rolled back. Episode lasted about 15 sec. Pt c/o not being able to see. She recovered completely. Vision normalized. 11/02/02 Medical record received for DOS 06/15/09.  Neuro visit. Patient passed out s/p vaccines. Brief dizziness before. Diaphoretic after. Pale. No postictal confusion. Nausea/dizziness x1hr after. One or two arm/leg jerks in phase. No rhythmic jerking. No pain. PE wnl. Neuro exam wnl. EEG abnormal but not relevant. Syncopal episode.  11/4/09 Medical records received for date 6/15/09. Neuro consult. DX: syncope. Presenting SX: episodes of passing out following vax, menactra, hepatitis, gardasil. Pt recalls brief dizziness prior to passing out, after passing out pt. states (+)sweating, (+)pale, (+)nausea and dizziness after episode. Parent witnessed 1 or 2 jerks of arms and legs in phase.  Assessment: PE WNL, EEG abnormal, showed some sharp waves in the left temporal region.
mild headache; body aches; This is a spontaneous report from a non-contactable consumer. A 39-year-old female patient (also reported as age at vaccination) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported), via an unspecified route of administration on 19Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number and expiry date: not reported) on 29Dec2020 (age: 39 years) for COVID-19 immunization. The patient was not diagnosed with COVID-19 prior to vaccination. On 19Jan2021, the patient experienced body aches. The patient had a mild headache on 20Jan2021. Unknown if treatment was given in response to the events. The patient was not pregnant at the time of vaccination. The outcome of the events was recovered on an unspecified date.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
PT recd series of 3 Engerix-B vaxs (20mcg) on 26JUL90, 26AUG90, & 26JAN91 & was a non-responder;
inj site pain; severe tiredness and fatigue  Narrative:  Day 2 - sore arm; Day 5 through 8 - severe tiredness and Fatigue
bronchospasm w/wheezing & itching of face 5 mins p/vax & rhinorrhea w/5-7 mins;
Not sure if it is vaccine related as I received my first dose 8 days ago. In any case, as of last night I've experienced headache, muscle pain (not on vaccination site) chills, joint pain, and feeling unwell. This has been going on for nearly 24 hours. Aches eased up when I took over the counter ibuprofen, but start right up when effect wears off.
PATIENT REPORTEDLY HAD 102 FEVER. NAUSEA/ VOMITING. DIFFICULTY BREATHING. SPENT 2 DAYS IN HOSPITAL.
Pt states after receiving vaccinations, experienced a high grade  fever for 3 days. Also states had itching and redness around injection site on left arm. Pt also states has been taking ibuprofen 600mg q4h to help control the pain. Chief complaint is pain and lipoma like pain in left arm described as "hard ball" in her arm.
Patient called the pharmacy and complained about rash and blisters like chickenpox all over her body on 2/19/2018. She was wondering if it is normal reaction from SHINGRIX that she was given on 1/23/2018. I recommended her to see her doctor to evaluate the reaction and called the patient on the night for follow-up. According to the patient, her doctor told her that it might not reaction from SHINGRIX. She has been on Methotrexate for psoriasis and stopped it recently. Her doctor drew her blood for lab to be make sure about it and for the second dose of SHINGRIX whether she can receive it or not. I asked her if her doctor prescribed or recommended any medications for the rash like antihistamine and she said he does not and she is doing fine now. I asked her let us know about the blood work result too. She sounds like she is really okay now.
Immediate tingling and heaviness all the way down my arm.  Within 5-10 minutes, started feeling dizzy/lightheaded and nauseous, like I might pass out.  Was taken to the nurse's station and given fluids and graham crackers and observed for 30 minutes.  Was feeling well enough to leave.  Later that evening and throughout the weekend, I continued to experience fatigue, lightheadedness, brain fog, nausea. two days later, I also developed a moderate headache and sore throat.  I slept long hours for two nights, and by Monday morning, the fatigue and nausea remained, but were mild.  Within a weak, my symptoms had dissipated.  However, on the morning of Day 8, my injection site had become more red, swollen, and itchy.  These symptoms are still present on Day 11.
The evening following vax administration & throughout the following 24 hrs, pt c/o fever 101 oral, nausea, pain & redness lt arm around inject site, swelling of  lt arm from shoulder to mid arm;
Within 5 minutes of receiving my vaccine, I suddenly felt the back of my mouth, throat, and back of my tongue feel numb. I also felt a slight nausea. The sensation lasted for about a minute. I told the staff at the hospital that was observing me. It started to subside gradually, but twice while I was still being observed the sensation came back, but not as strong and not for as long as it did the first time. I had no other symptoms. I want to add that I was not anxious about receiving the vaccine and nothing like this has ever happened to me before, but it was quite alarming at the time. I was observed for an hour in total after the shot. I was offered to go to the ER if I wanted to but I declined. It is now  about 3 hours since the shot and I feel ok now just slightly tired.
got the first dose of Shingrix on 2018 / second dose on Feb 2021; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too long in a 65-year-old female patient who received Herpes zoster (Shingrix) (batch number 95JR5, expiry date 5th November 2022) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in 2018).   In February 2021, the patient received the 2nd dose of Shingrix. In February 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.  Additional details were provided as follows: The patient received 2nd dose of Shingrix, later than the recommended interval, which led to lengthening of vaccination schedule. The reporter consented to follow up. No further information was reported.
precancerous polyp; during this surgery, she began to hemorrhage and lost "half her blood."; liver numbers went from 35 to 1,000; as a result of the transfusion she developed anemia; bad reaction to the transfusion; outpatient surgery for cataracts; arm was sore to the touch; This case was reported by a consumer via call center representative and described the occurrence of polyp in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 12th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On an unknown date, between 1 and 3 months after receiving Shingrix, the patient experienced polyp (serious criteria hospitalization), hemorrhage (serious criteria hospitalization and GSK medically significant), elevated liver enzymes (serious criteria hospitalization), anemia (serious criteria hospitalization), adverse event (serious criteria hospitalization), cataract (serious criteria GSK medically significant) and pain in arm. On an unknown date, the outcome of the polyp, hemorrhage, cataract and pain in arm were recovered/resolved and the outcome of the elevated liver enzymes and adverse event were unknown and the outcome of the anemia was not recovered/not resolved.   It was unknown if the reporter considered the polyp, hemorrhage, elevated liver enzymes, anemia, adverse event, cataract and pain in arm to be related to Shingrix.  Additional details were provided as follows: Post vaccination the patient's arm was sore to the touch for a couple of weeks.  On 05th November 2019, the patient was admitted to the hospital for a colectomy to remove a small portion of her colon due to a precancerous polyp. The reporter stated that during this surgery, she began to hemorrhage and lost half her blood. The reporter stated at that time her liver numbers went from 35 to 1,000 and that she had to have a blood transfusion.  She said that she had a bad reaction to the transfusion and as a result of the transfusion she developed anemia. She stated that while in the hospital she had to have all kinds of medical procedures including blood tests and a sonogram. The reporter stated that in November 2019, she also had outpatient surgery for cataracts.  The reporter consented to follow up. This case had been linked to the case US2020AMR015681, reported for same patient.
Patient has a large red area at site of injection and it is raised. Patient reports that it is worse than yesterday Note: she is also taking warfarin 5mg one and one-half daily.
swollen lips; swollen tongue; swollen throat; little white bumps on the inside of my bottom lip; Ive had thrush before but never to this extent.; pain; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), FORDYCE SPOTS (little white bumps on the inside of my bottom lip) and CANDIDA INFECTION (Ive had thrush before but never to this extent.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), FORDYCE SPOTS (little white bumps on the inside of my bottom lip), CANDIDA INFECTION (Ive had thrush before but never to this extent.) and PAIN (pain). At the time of the report, LIP SWELLING (swollen lips), SWOLLEN TONGUE (swollen tongue), PHARYNGEAL SWELLING (swollen throat), FORDYCE SPOTS (little white bumps on the inside of my bottom lip), CANDIDA INFECTION (Ive had thrush before but never to this extent.) and PAIN (pain) outcome was unknown.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
patient presented to ER with left sided chest pain. Chest x-ray and chest CT performed. Chest CT showed linear embolism in lingular branch of left pulmonary artery. EKG showed right bundle branch block which was different than last EKG in 2019. Patient treated with Eliquis 10mg BID x 7 days, then 5mg BID x 3 months.
Per MD's report - Significant redness and swelling localized to upper arm area: C/O feeling achy, vomiting multiple times  (x1 day) 3 day after received vaccine; No treatment.
rash; itches; Redness moving down the arm.; Hardness moving down the arm.; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash), PRURITUS (itches), ERYTHEMA (Redness moving down the arm.) and INDURATION (Hardness moving down the arm.) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history).    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash), PRURITUS (itches), ERYTHEMA (Redness moving down the arm.) and INDURATION (Hardness moving down the arm.). At the time of the report, RASH (rash), PRURITUS (itches), ERYTHEMA (Redness moving down the arm.) and INDURATION (Hardness moving down the arm.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       no concomitant medication given patient has taken Diphenhydramine HCl to mitigate the symptoms
Low grade fever, fussiness, very sleepy, reduced appetite. Lasted about 48 hours. Soreness and hard red spot at injection site for a few additional days.
Swollen lymph nodes under armpit area of left arm (where shot was administered). Urgent care told me to monitor the area for the next 7-10 days.
This spontaneous case was reported by a pharmacist and describes the occurrence of BONE PAIN (bone aches from the waist down) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 prophylaxis. No Medical History information was reported. On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced BONE PAIN (bone aches from the waist down). At the time of the report, BONE PAIN (bone aches from the waist down) outcome was unknown. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant products were not reported. The patient reports no other adverse reactions or side effects after the first vaccine. Treatment medications were not reported. This case was linked to MOD-2022-630013 (Patient Link).
Increase urination frequency and urgency; Urinary urgency; felt unusual warm; painful arm; felt dizzy; Could not sleep; did not feel good; This case was reported by a consumer via call center representative and described the occurrence of increased urinary frequency in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of rash (1st dose received on 20th June 2021, refer case US2021000069).   On 3rd October 2021, the patient received the 2nd dose of Shingrix (intramuscular). On 3rd October 2021, several hours after receiving Shingrix, the patient experienced increased urinary frequency, urinary urgency, feeling hot, painful arm, dizziness, insomnia and feeling bad. On an unknown date, the outcome of the increased urinary frequency, urinary urgency, feeling hot and dizziness were recovered/resolved and the outcome of the painful arm was not recovered/not resolved and the outcome of the insomnia and feeling bad were unknown.   It was unknown if the reporter considered the increased urinary frequency, urinary urgency, feeling hot, painful arm, dizziness, insomnia and feeling bad to be related to Shingrix.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was unknown. The patient received dose of Shingrix vaccine in the left deltoid and could not sleep last night and did not feel good, felt dizzy, felt unusual warm, painful arm, and increased urination frequency and urgency (had to urinate about 6 to 7 times last night). The above side effects were experienced a couple of hours later. In October 2021, the side effects dizziness, unusual warm, and increase urination frequency and urgency were resolved except painful arm. The status about inability to sleep last night was unknown. The reporter did not have full mailing address, fax number or an email address to healthcare professional. The reporter did not provide his date of birth, only stated a year. Also the reporter did not provide lot number, expiration date, and dosage. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021000069:same reporter - 1st dose
Warmth going through his mid-section of the body; Flashes of heat in the Pelvic area; Lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warmth going through his mid-section of the body), PELVIC DISCOMFORT (Flashes of heat in the Pelvic area) and DIZZINESS (Lightheaded) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE (SUBOXONE), ZOLPIDEM TARTRATE (AMBIEN) and ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced FEELING HOT (Warmth going through his mid-section of the body), PELVIC DISCOMFORT (Flashes of heat in the Pelvic area) and DIZZINESS (Lightheaded). At the time of the report, FEELING HOT (Warmth going through his mid-section of the body), PELVIC DISCOMFORT (Flashes of heat in the Pelvic area) and DIZZINESS (Lightheaded) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information provided.
Approx 14 hrs after Varicella injection, client noticed redness & swelling at site - approx 2 1/2" x 3" erythema with some induration. Dx with cellulitis at urgent. Resolved 2-3 d after KEFLEX started 3 -30 -11.
6mowf w/fever of 104.8 830PM pt taken to ER for eval-fever cont x 48hr;fever of 102.7 on 15OCT96;
Red elevated welt about 4 inches in diameter, like a bee sting.   Remained elevated for about 3-4 days and red for 14 days.  On day 10 became very itchy.
Within 10 days of 2nd dose, I developed heart palpitations. For approximately 1 week, they were every night, lasting approximately 10 minutes. On about the 5th night, the palpitations lasted for an hour. The following night, they lasted the entire night. The following day, I saw the Dr. at local clinic. Several tests (EKG, chest X-ray, metabolic panel, D dimer) were performed (all negative) and the condition was not present at that moment. For about 20 months, this condition persisted in a manageable manner, about 2x per week, with durations of approx. 10 minutes. In December of '22, it started to worsen. The frequency increases to 3-4 times per week and the duration increased to 20-30 minutes. On January 8, 2023, the frequency and duration further increased to every night, with episodes lasting 30-60 minutes. On January 12th, the episode lasted 3 hours and my resting heart rate (normally in low 40s) reached 120 bpm. At this time, I went to the ER at local hospital.   Again, several tests (EKG, chest X-ray, metabolic panel, D dimer) were performed and all were negative. However, because the condition was present, they were able to diagnose (as): Paroxysmal atrial fibrillation with RVR (HRC). The condition subsided naturally after 3 hours. As I type this report, I had experienced this condition 5 consecutive nights, with January 17 ending the consecutive string. At about the time of the 2nd dose, my VO2max also decreased from about 58 mL/kg-min to about 52 mL/kg-min.
both arms hives;face hives;SOB;vomited several times w/diarrhea;used DPH;saw MD;
Tiredness; muscle pain; pain at the shot area; This case was reported by a consumer via call center representative and described the occurrence of tiredness in a 66-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced tiredness, muscle pain and injection site pain. On an unknown date, the outcome of the tiredness, muscle pain and injection site pain were unknown.   It was unknown if the reporter considered the tiredness, muscle pain and injection site pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced the tiredness, muscle pain and pain at the shot area. The reporter asked if he/she could expect the side effects to go away within 24 to 48 hours or so.
Right leg numbness and unable to move it, partial right arm numbness and left leg numbness unable to walk. Bladder infection secondary at time. Severe back pain.
frozen shoulder; Adhesive capsulitis of left shoulder; decreased range of motion in left shoulder shortly after injection, followed by pain in same shoulder; decreased range of motion in left shoulder shortly after injection, followed by pain in same shoulder; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 45-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 11Nov2022 as dose number unknown (booster), single (Lot number: GJ3275) at the age of 45 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete;  unknown manufacturer), for COVID-19 immunization. The following information was reported: PERIARTHRITIS (non-serious) with onset 11Nov2022, outcome "unknown", described as "Adhesive capsulitis of left shoulder"; JOINT RANGE OF MOTION DECREASED (non-serious), ARTHRALGIA (non-serious) all with onset 11Nov2022, outcome "unknown" and all described as "decreased range of motion in left shoulder shortly after injection, followed by pain in same shoulder"; PERIARTHRITIS (non-serious) with onset 17Jan2023, outcome "unknown", described as "frozen shoulder". The events "adhesive capsulitis of left shoulder", "decreased range of motion in left shoulder shortly after injection, followed by pain in same shoulder" and "frozen shoulder" required physician office visit. Therapeutic measures were taken as a result of periarthritis, joint range of motion decreased, arthralgia, periarthritis.  Additional information: Started experiencing decreased range of motion in left shoulder shortly after injection, followed by pain in same shoulder. After self-treatment for a couple of months, sought treatment by orthopedic surgeon who ordered physical therapy. PT discussed causes which vaccines could be a cause for frozen shoulder and timing matched up. This was discovered on 17Jan2023 around 12pm. Event took place after use of product.
Headache, then blurry vision, numbness in right hand the right side of the face, numbness on right side of the body. Slurred speech. No treatment. Blurred vision lasted 5 minutes,numbness went away in about 1 hour. 10/6/09 PCP medical records neuro and ophth consults DOS 2/17/09 to 9/22/09. Assessment: Transient visual loss, headache, migraine, hyperopia. Patient presents with blurred vision, floaters. Tingling in hand, shoulder, facial area, down leg, felt that she would pass out. Lightheaded, nauseous. Numbness right side. Oral contraceptives.